Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

X4753

Sigma-Aldrich

XCT790

≥98% (HPLC), solid

Sinônimo(s):

3-[4-(2,4-Bis-trifluoromethylbenzyloxy)-3-methoxyphenyl]-2-cyano-N-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)acrylamide

Faça loginpara ver os preços organizacionais e de contrato

Selecione um tamanho

5 MG
R$ 1.924,00
25 MG
R$ 7.932,00

R$ 1.924,00


Previsão de entrega em14 de abril de 2025


Solicite uma grande encomenda

Selecione um tamanho

Alterar visualização
5 MG
R$ 1.924,00
25 MG
R$ 7.932,00

About This Item

Fórmula empírica (Notação de Hill):
C23H13F9N4O3S
Número CAS:
Peso molecular:
596.42
Número MDL:
Código UNSPSC:
12352202
ID de substância PubChem:
NACRES:
NA.77

R$ 1.924,00


Previsão de entrega em14 de abril de 2025


Solicite uma grande encomenda

Nível de qualidade

Ensaio

≥98% (HPLC)

Formulário

solid

cor

yellow

solubilidade

DMSO: ≥10 mg/mL

temperatura de armazenamento

2-8°C

cadeia de caracteres SMILES

COc1cc(ccc1OCc2ccc(cc2C(F)(F)F)C(F)(F)F)\C=C(/C#N)C(=O)Nc3nnc(s3)C(F)(F)F

InChI

1S/C23H13F9N4O3S/c1-38-17-7-11(6-13(9-33)18(37)34-20-36-35-19(40-20)23(30,31)32)2-5-16(17)39-10-12-3-4-14(21(24,25)26)8-15(12)22(27,28)29/h2-8H,10H2,1H3,(H,34,36,37)/b13-6+

chave InChI

HQFNFOOGGLSBBT-AWNIVKPZSA-N

Aplicação

XCT790 has been used:
  • as an estrogen-related receptor (ERR)α inverse agonist in C2C12 myotubes[1]
  • as an estrogen-related receptor (ERR)α inverse agonist to elucidate decidualization functionality of ERRα in endometrial embryonic stem cells[2]
  • as an autophagy inducer in human neuroblastoma SH-SY5Y and HeLa cell lines. [3]

Ações bioquímicas/fisiológicas

XCT 790 is a 5′adenosine monophosphate-activated protein kinase (AMPK) activator.[4] It also acts as a proton ionophore and an uncoupler of oxidative phosphorylation in mitochondria.[4] XCT790 impairs vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) expression[5] and exhibits suppression of endometrial tumor via estrogen-related receptor (ERRα) inhibition.[6] XCT790 mediates cell cycle arrest and favors apoptosis in triple-negative breast cancer (TNBC).[7]
XCT790 is a potent and specific inverse agonist of ERRα. Selective; showing no significant antagonist activity on related nuclear receptors, such as ERRγ or ERα at concentrations below 10 μM.
XCT790 is a potent and specific inverse agonist of ERRα. XCT790 is selective; showing no significant antagonist activity on related nuclear receptors, such as ERRγ or ERα at concentrations below 10 μM. XCT790 inhibits the constitutive activity of ERRα in both biochemical and cell-based assays. The IC50 value is 300-500 nM in transient transfection assays using GAL4-ERR LBD or full-length ERR with the mSHP promoter.

Frases de perigo

Declarações de precaução

Classificações de perigo

Aquatic Chronic 4

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Equipamento de proteção individual

Eyeshields, Gloves, type N95 (US)


Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Ying-Min Wu et al.
Oncotarget, 7(11), 12568-12581 (2016-02-13)
There is an urgent clinical need for targeted therapy approaches for triple-negative breast cancer (TNBC) patients. Increasing evidences suggested that the expression of estrogen-related receptor alpha (ERRα) was correlate with unfavorable clinical outcomes of breast cancer patients. We here show
Rasmus J O Sjögren et al.
Diabetologia, 64(9), 2077-2091 (2021-06-17)
Increased levels of branched-chain amino acids (BCAAs) are associated with type 2 diabetes pathogenesis. However, most metabolomic studies are limited to an analysis of plasma metabolites under fasting conditions, rather than the dynamic shift in response to a metabolic challenge.
W F Theeuwes et al.
Biochimica et biophysica acta. Molecular cell research, 1867(2), 118610-118610 (2019-11-19)
In muscle cells, the peroxisome proliferator-activated receptor γ co-activator 1 (PGC-1) signaling network, which has been shown to be disturbed in the skeletal muscle in several chronic diseases, tightly controls mitochondrial biogenesis and oxidative substrate metabolism. Previously, we showed that
Banu Eskiocak et al.
Biochemistry, 53(29), 4839-4846 (2014-07-08)
XCT 790 is widely used to inhibit estrogen-related receptor α (ERRα) activity as an inverse agonist. Here, we report that XCT 790 potently activates AMP kinase (AMPK) in a dose-dependent and ERRα-independent manner, with active concentrations more than 25-fold below
G Vargas et al.
Oncogene, 38(7), 950-964 (2018-11-28)
Bone is the most common metastatic site for breast cancer. Estrogen-related-receptor alpha (ERRα) has been implicated in cancer cell invasiveness. Here, we established that ERRα promotes spontaneous metastatic dissemination of breast cancer cells from primary mammary tumors to the skeleton.

Questions

Reviews

No rating value

Active Filters

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica